01 /What the compare tool does
The compare tool at apothify.com/compare lets you put two peptides side by side. Pick two from the library, and the tool renders both with the same six section structure used on the peptide pages: short summary, what it is, how it works, what researchers explore it for, safety and interactions, and research notes. Above the cards, the tool flags any known interaction between the two compounds drawn from the curated interaction matrix.
Compare is designed for researchers who already know what they are looking for or who are choosing between two reasonable candidates. The peptide finder is the better tool for open discovery; compare is the right tool once the candidate set is small.
02 /What to look at first
Start with category alignment. Are both peptides in the same research category, or are they cross category? Same category usually means overlapping mechanism; cross category means complementary or unrelated mechanisms.
Then look at the interaction flag above the cards. The tool surfaces one of four states: synergy, redundant, caution, or none.
Read both safety and interactions sections before forming any conclusion. The interaction flag captures the curated relationship; the per peptide safety section captures the rest.
03 /Reading the four interaction states
Synergy is the most useful flag for stack planning. It indicates the two compounds are commonly studied together in the literature with mechanisms that complement each other. The GHRH analog plus ghrelin receptor agonist pairing is the canonical synergy example.
Redundant is a flag against stacking. It indicates both compounds engage the same receptor or pathway, so combining them adds no clear signal and may complicate dose interpretation.
Caution is a flag for elevated handling care. It indicates overlapping pathway engagement that warrants reviewing the safety sections on both peptide pages before designing a combined protocol.
None means there is no curated interaction rule. It does not mean the two compounds are known to be safe together. It means the interaction matrix has nothing specific to say. Default to caution and read both safety sections.
04 /Comparing two peptides in the same family
When both peptides are in the same family (e.g., CJC 1295 no DAC and CJC 1295 with DAC, both GHRH analogs), the comparison usually comes down to duration of action, selectivity, and handling. Look at the half life or duration mentioned in the how it works section. Look at receptor selectivity language in the what researchers explore it for section. Look at the related peptides list at the bottom to see what each is typically compared with.
For sister compounds, the redundant flag usually applies. The research question is which one is the better tool for your specific protocol, not whether to combine them.
05 /Comparing two peptides across families
Cross family comparison (e.g., a GHRH analog vs a mitochondrial peptide) is the more common case for researchers planning a combination protocol. Here the question is whether the mechanisms are complementary, whether the safety profiles are independent, and whether there is any published literature on the combination.
Synergy flags surface most of the well documented complementary pairings in the Apothify library. None flags mean the matrix has no curated rule, which often means there is no published combination literature; treat the combination as exploratory and design accordingly.
06 /What compare does not do
Compare does not recommend a peptide. It surfaces facts side by side; the choice is yours. Apothify does not recommend peptides for any use.
Compare does not run a dose calculation, predict an experimental outcome, or model the kinetics of a combination. Those are protocol design problems that require your own research design.
Compare does not generate dosing advice, frequency advice, or route of administration advice. All Apothify products are research use only and not for human consumption.
07 /Emailing the comparison
Below the comparison cards is a small form to email the comparison to yourself. Submitting your email triggers an HTML email that mirrors the on page layout, with the same flag, the same card content, and links back to the full peptide pages. Useful for sharing with a colleague or for keeping a record.
The email is transactional (you initiated it) so there is no separate consent step. Apothify does not add the email to a marketing list unless you separately opt in via the newsletter.
08 /When to use compare vs finder vs library
Use the finder when you have a research interest but no candidate peptides yet. The finder walks you through four questions and ranks the library against your interests.
Use compare when you have two candidates and need to decide between them, or when you are evaluating a potential combination.
Use the library directly when you already know which peptide you want and need the full entry.
